Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing and able to give their informed consent to take part in the study
- People aged 18 or older, of any gender
- People who have a suspected pituitary adenoma (a growth on the pituitary gland in the brain) based on symptoms, blood test results, and/or medical imaging
- People who have previously had a specific type of brain scan called an 11C-Met-PET/CT scan
Who may not be able to join:
- People who are unable to give informed consent to participate
- People who are pregnant or possibly pregnant
- People who are unable to lie flat and still for 30 to 60 minutes
- People whose body size exceeds the physical dimensions of the scanning equipment
- People with a known allergy to contrast dye used in medical imaging scans
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mark Gurnell, MD, PhD, Cambridge University Hospitals NHS Foundation Trust
Phone: 01223 250882
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Maximum Standardized Uptake Values (SUVmax) over pituitary tumour on each of 11C-methionine and 18F-fluoroethyltyrosine PET scans
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.